Toll Free: 1-888-928-9744

Europe Chronic Kidney Disease (CKD) Drugs Industry 2016 Market Research Report

Published: Jun 13, 2016 | Pages: 130 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The Europe Chronic Kidney Disease (CKD) Drugs Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Chronic Kidney Disease (CKD) Drugs industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Chronic Kidney Disease (CKD) Drugs market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Chronic Kidney Disease (CKD) Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 147 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


 Table of Contents
1 Industry Overview 1.1 Definition and Specifications of Chronic Kidney Disease (CKD) Drugs 1.1.1 Definition of Chronic Kidney Disease (CKD) Drugs 1.1.2 Specifications of Chronic Kidney Disease (CKD) Drugs 1.2 Classification of Chronic Kidney Disease (CKD) Drugs 1.3 Applications of Chronic Kidney Disease (CKD) Drugs 1.4 Industry Chain Structure of Chronic Kidney Disease (CKD) Drugs 1.5 Industry Overview of Chronic Kidney Disease (CKD) Drugs 1.6 Industry Policy Analysis of Chronic Kidney Disease (CKD) Drugs 1.7 Industry News Analysis of Chronic Kidney Disease (CKD) Drugs 2 Manufacturing Cost Structure Analysis of Chronic Kidney Disease (CKD) Drugs 2.1 Bill of Materials (BOM) of Chronic Kidney Disease (CKD) Drugs 2.2 BOM Price Analysis of Chronic Kidney Disease (CKD) Drugs 2.3 Labor Cost Analysis of Chronic Kidney Disease (CKD) Drugs 2.4 Depreciation Cost Analysis of Chronic Kidney Disease (CKD) Drugs 2.5 Manufacturing Cost Structure Analysis of Chronic Kidney Disease (CKD) Drugs 2.6 Manufacturing Process Analysis of Chronic Kidney Disease (CKD) Drugs 2.7 Europe Price, Cost and Gross of Chronic Kidney Disease (CKD) Drugs 2011-2016 3 Technical Data and Manufacturing Plants Analysis 3.1 Capacity and Commercial Production Date of Europe Key Manufacturers in 2015 3.2 Manufacturing Plants Distribution of Europe Key Chronic Kidney Disease (CKD) Drugs Manufacturers in 2015 3.3 R&D Status and Technology Source of Europe Chronic Kidney Disease (CKD) Drugs Key Manufacturers in 2015 3.4 Raw Materials Sources Analysis of Europe Chronic Kidney Disease (CKD) Drugs Key Manufacturers in 2015 4 Production Analysis of Chronic Kidney Disease (CKD) Drugs by Regions, Type, and Applications 4.1 Europe Production of Chronic Kidney Disease (CKD) Drugs by Regions 2011-2016 4.2 Europe Production of Chronic Kidney Disease (CKD) Drugs by Type 2011-2016 4.3 Europe Sales of Chronic Kidney Disease (CKD) Drugs by Applications 2011-2016 4.4 Price Analysis of Europe Chronic Kidney Disease (CKD) Drugs Key Manufacturers in 2015 4.5 Europe Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Chronic Kidney Disease (CKD) Drugs 2011-2016 5 Consumption Volume and Consumption Value Analysis of Chronic Kidney Disease (CKD) Drugs by Regions 5.1 Europe Consumption Volume of Chronic Kidney Disease (CKD) Drugs by Regions 2011-2016 5.2 Europe Consumption Value of Chronic Kidney Disease (CKD) Drugs by Regions 2011-2016 5.3 Europe Consumption Price Analysis of Chronic Kidney Disease (CKD) Drugs by Regions 2011-2016 6 Analysis of Chronic Kidney Disease (CKD) Drugs Production, Supply, Sales and Market Status 2011-2016 6.1 Capacity, Production, Sales, and Revenue of Chronic Kidney Disease (CKD) Drugs 2011-2016 6.2 Production Market Share and Sales Market Share Analysis of Chronic Kidney Disease (CKD) Drugs 2014-2015 6.3 Sales Overview of Chronic Kidney Disease (CKD) Drugs 2011-2016 6.4 Supply, Consumption and Gap of Chronic Kidney Disease (CKD) Drugs 2011-2016 6.5 Import, Export and Consumption of Chronic Kidney Disease (CKD) Drugs 2011-2016 6.6 Cost, Price, Revenue and Gross Margin of Chronic Kidney Disease (CKD) Drugs 2011-2016 7 Analysis of Chronic Kidney Disease (CKD) Drugs Industry Key Manufacturers 7.1 Actavi 7.1.1 Company Profile 7.1.2 Product Picture and Specifications 7.1.2.1 Type I 7.1.2.2 Type II 7.1.2.3 Type III 7.1.3 Capacity, Production, Price, Cost, Gross and Revenue 7.1.4 Contact Information 7.2 Amgen 7.2.1 Company Profile 7.2.2 Product Picture and Specifications 7.2.2.1 Type I 7.2.2.2 Type II 7.2.2.3 Type III 7.2.3 Capacity, Production, Price, Cost, Gross and Revenue 7.2.4 Contact Information 7.3 F. Hoffmann-La Roche 7.3.1 Company Profile 7.3.2 Product Picture and Specifications 7.3.2.1 Type I 7.3.2.2 Type II 7.3.2.3 Type III 7.3.3 Capacity, Production, Price, Cost, Gross and Revenue 7.3.4 Contact Information 7.4 Sanofi 7.4.1 Company Profile 7.4.2 Product Picture and Specifications 7.4.2.1 Type I 7.4.2.2 Type II 7.4.2.3 Type III 7.4.3 Capacity, Production, Price, Cost, Gross and Revenue 7.4.4 Contact Information 7.5 Abbott 7.5.1 Company Profile 7.5.2 Product Picture and Specifications 7.5.2.1 Type I 7.5.2.2 Type II 7.5.2.3 Type III 7.5.3 Capacity, Production, Price, Cost, Gross and Revenue 7.5.4 Contact Information 7.6 Akebia Therapeutics 7.6.1 Company Profile 7.6.2 Product Picture and Specifications 7.6.2.1 Type I 7.6.2.2 Type II 7.6.2.3 Type III 7.6.3 Capacity, Production, Price, Cost, Gross and Revenue 7.6.4 Contact Information 7.7 AMAG Pharmaceuticals 7.7.1 Company Profile 7.7.2 Product Picture and Specifications 7.7.2.1 Type I 7.7.2.2 Type II 7.7.2.3 Type III 7.7.3 Capacity, Production, Price, Cost, Gross and Revenue 7.7.4 Contact Information 7.8 Cara Therapeutics 7.8.1 Company Profile 7.8.2 Product Picture and Specifications 7.8.2.1 Type I 7.8.2.2 Type II 7.8.2.3 Type III 7.8.3 Capacity, Production, Price, Cost, Gross and Revenue 7.8.4 Contact Information 7.9 FibroGen 7.9.1 Company Profile 7.9.2 Product Picture and Specifications 7.9.2.1 Type I 7.9.2.2 Type II 7.9.2.3 Type III 7.9.3 Capacity, Production, Price, Cost, Gross and Revenue 7.9.4 Contact Information 7.10 Keryx Biopharmaceuticals 7.10.1 Company Profile 7.10.2 Product Picture and Specifications 7.10.2.1 Type I 7.10.2.2 Type II 7.10.2.3 Type III 7.10.3 Capacity, Production, Price, Cost, Gross and Revenue 7.10.4 Contact Information 7.11 Reata Pharmaceuticals 7.11.1 Company Profile 7.11.2 Product Picture and Specifications 7.11.2.1 Type I 7.11.2.2 Type II 7.11.2.3 Type III 7.11.3 Capacity, Production, Price, Cost, Gross and Revenue 7.11.4 Contact Information 7.12 OPKO Health 7.12.1 Company Profile 7.12.2 Product Picture and Specifications 7.12.2.1 Type I 7.12.2.2 Type II 7.12.2.3 Type III 7.12.3 Capacity, Production, Price, Cost, Gross and Revenue 7.12.4 Contact Information 7.13 Raptor Pharmaceuticals 7.13.1 Company Profile 7.13.2 Product Picture and Specifications 7.13.2.1 Type I 7.13.2.2 Type II 7.13.2.3 Type III 7.13.3 Capacity, Production, Price, Cost, Gross and Revenue 7.13.4 Contact Information 7.14 Regulus Therapeutics 7.14.1 Company Profile 7.14.2 Product Picture and Specifications 7.14.2.1 Type I 7.14.2.2 Type II 7.14.2.3 Type III 7.14.3 Capacity, Production, Price, Cost, Gross and Revenue 7.14.4 Contact Information 7.15 Rockwell Medical 7.15.1 Company Profile 7.15.2 Product Picture and Specifications 7.15.2.1 Type I 7.15.2.2 Type II 7.15.2.3 Type III 7.15.3 Capacity, Production, Price, Cost, Gross and Revenue 7.15.4 Contact Information 7.16 Shield Therapeutics 7.16.1 Company Profile 7.16.2 Product Picture and Specifications 7.16.2.1 Type I 7.16.2.2 Type II 7.16.2.3 Type III 7.16.3 Capacity, Production, Price, Cost, Gross and Revenue 7.16.4 Contact Information 7.17 Takeda Pharmaceuticals 7.17.1 Company Profile 7.17.2 Product Picture and Specifications 7.17.2.1 Type I 7.17.2.2 Type II 7.17.2.3 Type III 7.17.3 Capacity, Production, Price, Cost, Gross and Revenue 7.17.4 Contact Information 7.18 Vifor Pharma Ltd 7.18.1 Company Profile 7.18.2 Product Picture and Specifications 7.18.2.1 Type I 7.18.2.2 Type II 7.18.2.3 Type III 7.18.3 Capacity, Production, Price, Cost, Gross and Revenue 7.18.4 Contact Information 7.19 ZS Pharma 7.19.1 Company Profile 7.19.2 Product Picture and Specifications 7.19.2.1 Type I 7.19.2.2 Type II 7.19.2.3 Type III 7.19.3 Capacity, Production, Price, Cost, Gross and Revenue 7.19.4 Contact Information 8 Price and Gross Margin Analysis 8.1 Analysis of Price 8.2 Gross Margin Analysis 8.3 Price Comparison by Regions 8.4 Price Analysis of Different Chronic Kidney Disease (CKD) Drugs Product Types 8.5 Market Share Analysis of Different Chronic Kidney Disease (CKD) Drugs Price Levels 8.6 Gross Margin Analysis of Different Chronic Kidney Disease (CKD) Drugs Applications 9 Marketing Trader or Distributor Analysis of Chronic Kidney Disease (CKD) Drugs 9.1 Marketing Channels Status of Chronic Kidney Disease (CKD) Drugs 9.2 Traders or Distributors of Chronic Kidney Disease (CKD) Drugs with Contact Information 9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Chronic Kidney Disease (CKD) Drugs 9.4 Europe Import, Export and Trade Analysis of Chronic Kidney Disease (CKD) Drugs 10 Development Trend of Chronic Kidney Disease (CKD) Drugs Industry 2016-2021 10.1 Capacity and Production Overview of Chronic Kidney Disease (CKD) Drugs 2016-2021 10.2 Production Market Share by Product Types of Chronic Kidney Disease (CKD) Drugs 2016-2021 10.3 Sales and Sales Revenue Overview of Chronic Kidney Disease (CKD) Drugs 2016-2021 10.4 Europe Sales of Chronic Kidney Disease (CKD) Drugs by Applications 2016-2021 10.5 Import, Export and Consumption of Chronic Kidney Disease (CKD) Drugs 2016-2021 10.6 Cost, Price, Revenue and Gross Margin of Chronic Kidney Disease (CKD) Drugs 2016-2021 11 Industry Chain Suppliers of Chronic Kidney Disease (CKD) Drugs with Contact Information 11.1 Major Raw Materials Suppliers of Chronic Kidney Disease (CKD) Drugs with Contact Information 11.2 Manufacturing Equipment Suppliers of Chronic Kidney Disease (CKD) Drugs with Contact Information 11.3 Major Players of Chronic Kidney Disease (CKD) Drugs with Contact Information 11.4 Key Consumers of Chronic Kidney Disease (CKD) Drugs with Contact Information 11.5 Supply Chain Relationship Analysis of Chronic Kidney Disease (CKD) Drugs 12 New Project Investment Feasibility Analysis of Chronic Kidney Disease (CKD) Drugs 12.1 New Project SWOT Analysis of Chronic Kidney Disease (CKD) Drugs 12.2 New Project Investment Feasibility Analysis of Chronic Kidney Disease (CKD) Drugs 13 Conclusion of the Europe Chronic Kidney Disease (CKD) Drugs Industry 2016 Market Research Report
List of Tables and Figures
Figure Picture of Chronic Kidney Disease (CKD) Drugs Table Product Specifications of Chronic Kidney Disease (CKD) Drugs Table Classification of Chronic Kidney Disease (CKD) Drugs Figure Europe Sales Market Share of Chronic Kidney Disease (CKD) Drugs by Product Types in 2015 Table Applications of Chronic Kidney Disease (CKD) Drugs Figure Europe Sales Market Share of Chronic Kidney Disease (CKD) Drugs by Applications in 2015 Figure Industry Chain Structure of Chronic Kidney Disease (CKD) Drugs Table Europe Industry Overview of Chronic Kidney Disease (CKD) Drugs Table Industry Policy of Chronic Kidney Disease (CKD) Drugs Table Industry News List of Chronic Kidney Disease (CKD) Drugs Table Bill of Materials (BOM) of Chronic Kidney Disease (CKD) Drugs Table Bill of Materials (BOM) Price of Chronic Kidney Disease (CKD) Drugs Table Labor Cost of Chronic Kidney Disease (CKD) Drugs Table Depreciation Cost of Chronic Kidney Disease (CKD) Drugs Table Manufacturing Cost Structure Analysis of Chronic Kidney Disease (CKD) Drugs in 2015 Figure Manufacturing Process Analysis of Chronic Kidney Disease (CKD) Drugs Table Europe Price Analysis of Chronic Kidney Disease (CKD) Drugs 2011-2016 (USD/Unit) Table Europe Cost Analysis of Chronic Kidney Disease (CKD) Drugs 2011-2016 (USD/Unit) Table Europe Gross Analysis of Chronic Kidney Disease (CKD) Drugs 2011-2016 Table Capacity (K Units) and Commercial Production Date of Europe Chronic Kidney Disease (CKD) Drugs Key Manufacturers in 2015 Table Manufacturing Plants Distribution of Europe Key Chronic Kidney Disease (CKD) Drugs Manufacturers in 2015 Table R&D Status and Technology Source of Europe Chronic Kidney Disease (CKD) Drugs Key Manufacturers in 2015 Table Raw Materials Sources Analysis of Europe and Europe Chronic Kidney Disease (CKD) Drugs Key Manufacturers in 2015 Table Europe Production of Chronic Kidney Disease (CKD) Drugs by Regions 2011-2016 (K Units) Table Europe Production Market Share of Chronic Kidney Disease (CKD) Drugs by Regions 2011-2016 Figure Europe Production Market Share of Chronic Kidney Disease (CKD) Drugs by Regions in 2014 Figure Europe Production Market Share of Chronic Kidney Disease (CKD) Drugs by Regions in 2015 Table Europe Production of Chronic Kidney Disease (CKD) Drugs by Types in 2011-2016 (K Units) Table Europe Production Market Share of Chronic Kidney Disease (CKD) Drugs by Type in 2011-2016 Figure Europe Production Market Share of Chronic Kidney Disease (CKD) Drugs by Type in 2014 Figure Europe Production Market Share of Chronic Kidney Disease (CKD) Drugs by Type in 2015 Table Europe Sales of Chronic Kidney Disease (CKD) Drugs by Applications 2011-2016 (K Units) Table Europe Production Market Share of Chronic Kidney Disease (CKD) Drugs by Applications 2011-2016 Figure Europe Production Market Share of Chronic Kidney Disease (CKD) Drugs by Applications in 2014 Figure Europe Production Market Share of Chronic Kidney Disease (CKD) Drugs by Applications in 2015 Table Price Comparison of Europe Chronic Kidney Disease (CKD) Drugs Key Manufacturers in 2015 (USD/Unit) Table Europe Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Chronic Kidney Disease (CKD) Drugs 2011-2016 Table Europe Consumption Volume of Chronic Kidney Disease (CKD) Drugs by Regions 2011-2016 (K Units) Table Europe Consumption Volume Market Share of Chronic Kidney Disease (CKD) Drugs by Regions 2011-2016 Figure Europe Consumption Volume Market Share of Chronic Kidney Disease (CKD) Drugs by Regions in 2014 Figure Europe Consumption Volume Market Share of Chronic Kidney Disease (CKD) Drugs by Regions in 2015 Table Europe Consumption Value of Chronic Kidney Disease (CKD) Drugs by Regions 2011-2016 (M USD) Table Europe Consumption Value Market Share of Chronic Kidney Disease (CKD) Drugs by Regions 2011-2016 Figure Europe Consumption Value Market Share of Chronic Kidney Disease (CKD) Drugs by Regions in 2014 Figure Europe Consumption Value Market Share of Chronic Kidney Disease (CKD) Drugs by Regions in 2015 Table Consumption Price of Chronic Kidney Disease (CKD) Drugs by Regions 2011-2016 (USD/Unit) Table Europe and Major Manufacturers Capacity of Chronic Kidney Disease (CKD) Drugs 2011-2016 (K Units) Table Europe Capacity Market Share of Major Chronic Kidney Disease (CKD) Drugs Manufacturers 2011-2016 Table Europe and Major Manufacturers Production of Chronic Kidney Disease (CKD) Drugs 2011-2016 (K Units) Table Europe Production Market Share of Major Chronic Kidney Disease (CKD) Drugs Manufacturers 2011-2016 Table Europe and Major Manufacturers Sales of Chronic Kidney Disease (CKD) Drugs 2011-2016 (K Units) Table Europe Sales Market Share of Major Chronic Kidney Disease (CKD) Drugs Manufacturers 2011-2016 Table Europe and Major Manufacturers Sales Revenue of Chronic Kidney Disease (CKD) Drugs 2011-2016 (M USD) Table Europe Sales Revenue Market Share of Major Chronic Kidney Disease (CKD) Drugs Manufacturers 2011-2016 Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Chronic Kidney Disease (CKD) Drugs 2011-2016 Figure Europe Capacity Utilization Rate of Chronic Kidney Disease (CKD) Drugs 2011-2016 Figure Europe Sales Revenue (M USD) and Growth Rate of Chronic Kidney Disease (CKD) Drugs 2011-2016 Figure Europe Production Market Share of Major Chronic Kidney Disease (CKD) Drugs Manufacturers in 2014 Figure Europe Production Market Share of Major Chronic Kidney Disease (CKD) Drugs Manufacturers in 2015 Figure Europe Sales Market Share of Major Chronic Kidney Disease (CKD) Drugs Manufacturers in 2014 Figure Europe Sales Market Share of Major Chronic Kidney Disease (CKD) Drugs Manufacturers in 2015 Figure Europe Sales (K Units) and Growth Rate of Chronic Kidney Disease (CKD) Drugs 2011-2016 Table Europe Supply, Consumption and Gap of Chronic Kidney Disease (CKD) Drugs 2011-2016 (K Units) Table Europe Import, Export and Consumption of Chronic Kidney Disease (CKD) Drugs 2011-2016 (K Units) Table Price of Europe Chronic Kidney Disease (CKD) Drugs Major Manufacturers 2011-2016 (USD/Unit) Table Gross Margin of Europe Chronic Kidney Disease (CKD) Drugs Major Manufacturers 2011-2016 Table Europe and Major Manufacturers Revenue of Chronic Kidney Disease (CKD) Drugs 2011-2016 (M USD) Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Chronic Kidney Disease (CKD) Drugs 2011-2016 Table Actavi Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Actavi Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Actavi 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Actavi 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Actavi 2011-2016 Table Actavi Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Amgen Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Amgen 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Amgen 2011-2016 Table Amgen Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table F. Hoffmann-La Roche Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of F. Hoffmann-La Roche Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of F. Hoffmann-La Roche 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of F. Hoffmann-La Roche 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of F. Hoffmann-La Roche 2011-2016 Table F. Hoffmann-La Roche Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Sanofi Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Sanofi 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Sanofi 2011-2016 Table Sanofi Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Abbott Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Abbott Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Abbott 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Abbott 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Abbott 2011-2016 Table Abbott Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Akebia Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Akebia Therapeutics Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Akebia Therapeutics 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Akebia Therapeutics 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Akebia Therapeutics 2011-2016 Table Akebia Therapeutics Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table AMAG Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of AMAG Pharmaceuticals Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of AMAG Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of AMAG Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of AMAG Pharmaceuticals 2011-2016 Table AMAG Pharmaceuticals Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Cara Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Cara Therapeutics Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Cara Therapeutics 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Cara Therapeutics 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Cara Therapeutics 2011-2016 Table Cara Therapeutics Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table FibroGen Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of FibroGen Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of FibroGen 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of FibroGen 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of FibroGen 2011-2016 Table FibroGen Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Keryx Biopharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Keryx Biopharmaceuticals Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Keryx Biopharmaceuticals 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Keryx Biopharmaceuticals 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Keryx Biopharmaceuticals 2011-2016 Table Keryx Biopharmaceuticals Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Reata Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Reata Pharmaceuticals Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Reata Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Reata Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Reata Pharmaceuticals 2011-2016 Table Reata Pharmaceuticals Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table OPKO Health Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of OPKO Health Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of OPKO Health 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of OPKO Health 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of OPKO Health 2011-2016 Table OPKO Health Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Raptor Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Raptor Pharmaceuticals Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Raptor Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Raptor Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Raptor Pharmaceuticals 2011-2016 Table Raptor Pharmaceuticals Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Regulus Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Regulus Therapeutics Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Regulus Therapeutics 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Regulus Therapeutics 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Regulus Therapeutics 2011-2016 Table Regulus Therapeutics Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Rockwell Medical Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Rockwell Medical Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Rockwell Medical 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Rockwell Medical 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Rockwell Medical 2011-2016 Table Rockwell Medical Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Shield Therapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Shield Therapeutics Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Shield Therapeutics 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Shield Therapeutics 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Shield Therapeutics 2011-2016 Table Shield Therapeutics Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Takeda Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Takeda Pharmaceuticals Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Takeda Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Takeda Pharmaceuticals 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Takeda Pharmaceuticals 2011-2016 Table Takeda Pharmaceuticals Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Vifor Pharma Ltd Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of Vifor Pharma Ltd Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Vifor Pharma Ltd 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of Vifor Pharma Ltd 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of Vifor Pharma Ltd 2011-2016 Table Vifor Pharma Ltd Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table ZS Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc) Figure Chronic Kidney Disease (CKD) Drugs Picture and Specifications of ZS Pharma Table Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of ZS Pharma 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Capacity (K Units), Production (K Units) and Growth Rate of ZS Pharma 2011-2016 Figure Chronic Kidney Disease (CKD) Drugs Production (K Units) and Europe Market Share of ZS Pharma 2011-2016 Table ZS Pharma Chronic Kidney Disease (CKD) Drugs SWOT Analysis Table Chronic Kidney Disease (CKD) Drugs Price by Regions 2011-2016 Table Chronic Kidney Disease (CKD) Drugs Price by Product Types 2011-2016 Table Chronic Kidney Disease (CKD) Drugs Price by Companies 2011-2016 Table Chronic Kidney Disease (CKD) Drugs Gross Margin by Companies 2011-2016 Table Price Comparison of Chronic Kidney Disease (CKD) Drugs by Regions 2011-2016 (USD/Unit) Table Price of Different Chronic Kidney Disease (CKD) Drugs Product Types (USD/Unit) Table Market Share of Different Chronic Kidney Disease (CKD) Drugs Price Level Table Gross Margin of Different Chronic Kidney Disease (CKD) Drugs Applications Table Marketing Channels Status of Chronic Kidney Disease (CKD) Drugs Table Traders or Distributors of Chronic Kidney Disease (CKD) Drugs with Contact Information Table Ex-work Price, Channel Price and End Buyer Price of Chronic Kidney Disease (CKD) Drugs (USD/Unit) in 2015 Table Europe Import, Export, and Trade of Chronic Kidney Disease (CKD) Drugs (K Units) Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Chronic Kidney Disease (CKD) Drugs 2016-2021 Figure Europe Capacity Utilization Rate of Chronic Kidney Disease (CKD) Drugs 2016-2021 Table Europe Chronic Kidney Disease (CKD) Drugs Production by Type 2016-2021 (K Units) Table Europe Chronic Kidney Disease (CKD) Drugs Production Market Share by Type 2016-2021 Figure Europe Production Market Share of Chronic Kidney Disease (CKD) Drugs by Type in 2021 Figure Europe Sales (K Units) and Growth Rate of Chronic Kidney Disease (CKD) Drugs 2016-2021 Figure Europe Sales Revenue (Million USD) and Growth Rate of Chronic Kidney Disease (CKD) Drugs 2016-2021 Figure Europe Sales of Chronic Kidney Disease (CKD) Drugs by Applications 2016-2021 (K Units) Table Europe Production Market Share of Chronic Kidney Disease (CKD) Drugs by Applications 2016-2021 Figure Europe Production Market Share of Chronic Kidney Disease (CKD) Drugs by Applications in 2021 Table Europe Production, Import, Export and Consumption of Chronic Kidney Disease (CKD) Drugs 2016-2021 (K Units) Table Europe Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Chronic Kidney Disease (CKD) Drugs 2016-2021 Table Major Raw Materials Suppliers of Chronic Kidney Disease (CKD) Drugs with Contact Information Table Manufacturing Equipment Suppliers of Chronic Kidney Disease (CKD) Drugs with Contact Information Table Major Players of Chronic Kidney Disease (CKD) Drugs with Contact Information Table Key Consumers of Chronic Kidney Disease (CKD) Drugs with Contact Information Table Supply Chain Relationship Analysis of Chronic Kidney Disease (CKD) Drugs Table New Project SWOT Analysis of Chronic Kidney Disease (CKD) Drugs Table New Project Investment Feasibility Analysis of Chronic Kidney Disease (CKD) Drugs Table Part of Interviewees Record List



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global electric water heaters market is expected to be valued at USD 29,322.4 million by 2022, as per a new research report by Radiant Insights, Inc. Escalating demand across extensive range of domestic applications is expected to drive demand. Evolv

Read More...

Global LCP (Liquid Crystal Polymer) industry is forecasted to reach USD 1.23 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing trend towards developing militarized components and connectors are likely to drive the demand

Read More...

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...
Choose License Type
Single User - US $3600
Multi User - US $7200
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify